TREM-2 serves as a negative immune regulator through Syk pathway in an IL-10 dependent manner in lung cancer

During infection, triggering receptor expressed on myeloid cells-2 (TREM-2) restrains dendritic cells (DCs) and macrophages (MΦs) phagocytosis, as well as reduces pro-inflammatory cytokines release through DNAX-activation protein 12 (DAP12) signaling. However, the role of TREM-2 signaling in cancer...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncotarget
Päätekijät: Yao, Yinan, Li, Hequan, Chen, Junjun, Xu, Weiyi, Yang, Guangdie, Bao, Zhang, Xia, Dajing, Lu, Guohua, Hu, Shuwen, Zhou, Jianying
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Impact Journals LLC 2016
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5045421/
https://ncbi.nlm.nih.gov/pubmed/27102437
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.8813
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia